Varenicline Hydrochloride

• CAT Number: I002757
• CAS Number: 230615-23-3
• Molecular Formula: C13H14ClN3
• Molecular Weight: 247.72
• Purity: ≥95%
• Synonyms: (6R)-7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline hydrochloride
• Target: Neuronal Signaling
• Solubility: DMSO: ＞ 2.5 mg/mL
• Storage: Store at -20C
• IUPAC Name: 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene;hydrochloride
• InChI: InChI=1S/C13H13N3.ClH/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1;/h1-2,4-5,8-9,14H,3,6-7H2;1H
• InChIKey: ZUCZFANFKYSVKF-UHFFFAOYSA-N
• SMILES: C1C2CNCC1C3=CC4=NC=CN=C4C=C23.Cl

Varenicline Hydrochloride(CAT: I002757) is a pharmaceutical compound primarily used as a smoking cessation aid. It functions as a partial agonist at the α4β2 nicotinic acetylcholine receptors, reducing cravings and withdrawal symptoms while simultaneously diminishing the rewarding effects of nicotine. This dual action makes it an effective option for individuals seeking to quit smoking. In research contexts, Varenicline Hydrochloride is also studied for its effects on neurological pathways associated with addiction and dependency. With high specificity and bioavailability, it is a valuable tool for exploring neurochemical mechanisms and potential therapeutic applications in addiction treatment and related neuropsychiatric disorders.